Tools
Upgrade to Pro 🌟

Upgrade for Pro stock ideas, Al signals, and more search.

Learn More

MNTL

Tema Neuroscience and Mental Health ETF · NAS

  • Category Health Care
  • Expense Ratio 0.75%
  • Listing Date Jan 23, 2024
  • Volume 43.0
  • Market Cap (AUM) $11.04M

Performance

-6.53%

1W

-8.89%

1M

-8.09%

3M

-1.12%

6M

-1.61%

YTD

-1.61%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Vertex Pharmaceuticals IncorporatedVRTX5.92%
  • Eli Lilly and CompanyLLY5.51%
  • Regeneron Pharmaceuticals, Inc.REGN4.90%
  • Biogen Inc.BIIB4.67%
  • Neurocrine Biosciences, Inc.NBIX4.32%
  • Denali Therapeutics Inc.DNLI4.21%
  • Stryker CorporationSYK3.85%
  • argenx SE ADRARGX3.59%
  • Teva Pharmaceutical Industries Limited Sponsored ADRTEVA3.40%
  • Crinetics Pharmaceuticals IncCRNX3.36%

Technical Analysis of MNTL 2024-11-18

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 3, Oscillators Score at 36, and a Technical Score of 20, indicating overall weakness in price momentum and suggesting caution for potential investors. The low scores across all categories highlight a lack of bullish signals in the current market environment.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.